A recent study also demonstrated that lapachol ameliorates NAFLD progression by directly inhibiting PKM2 phosphorylation and nuclear translocation, which then suppresses Kupffer cell M1 polarization [110]. Here, PKM is linked to metabolic dysfunction-associated steatotic liver disease.